Skip to main content

Treatment Refractory MAC Lung Disease clinical trials at UCSF

1 research study open to eligible people

Treatment refractory MAC lung disease is a lung infection that does not get better with usual treatments. UCSF is running a study to test if an inhaled medicine called Clofazimine can help. This study looks at how safe and effective this new treatment is for patients.

Showing trials for

Our lead scientists for Treatment Refractory MAC Lung Disease research studies include .